We did not characterize our tumor samples with respect to genetic alterations that are common in glioblastomas: TERT promoter mutation, EGFR amplification, or gain of chromosome 7 combined with loss of chromosome 10 (2), and so we do not know whether these genetic alterations would influence the inflammatory environment of glioblastoma. This evidence concerns the gene TERT and neoplasm.